logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

ZTO EXPRESS-W (02057) repurchased approximately 136,200 shares for approximately US$2.6755 million on September 28.

date
12:02 29/09/2026
avatar
GMT Eight
ZTO EXPRESS-W (02057) announced that on September 28, 2026, it repurchased approximately 136,200 shares for approximately US$2.6755 million.
ZTO EXPRESS-W (02057) announced that on September 28, 2026, it repurchased approximately 136,200 shares for approximately US$2.6755 million.
Related Articles
China Stock
Jiangsu Hengrui Pharmaceuticals (600276.SH) signed a licensing agreement with Novo Nordisk A/S for the HRS-1596 project.
HK Stock
HARBIN BANK (06138) Enhances and Expands Agricultural Services to Support High-Quality Development of Agriculture in Heilongjiang
HK Stock
Jiangsu Hengrui Pharmaceuticals (01276) licenses exclusive overseas rights to HRS-1596 to Novo, with a potential transaction value of up to US$2.6 billion.
Jiangsu Hengrui Pharmaceuticals (600276.SH) signed a licensing agreement with Novo Nordisk A/S for the HRS-1596 project.
China Stock
HARBIN BANK (06138) Enhances and Expands Agricultural Services to Support High-Quality Development of Agriculture in Heilongjiang
HK Stock
Jiangsu Hengrui Pharmaceuticals (01276) licenses exclusive overseas rights to HRS-1596 to Novo, with a potential transaction value of up to US$2.6 billion.
HK Stock
RECOMMEND
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
Why ATGL's Small Scale Could Become an Advantage in Enterprise AI
icon
25/09/2026
From IT Services to Enterprise AI: What ATGL Must Prove Next
From IT Services to Enterprise AI: What ATGL Must Prove Next
icon
24/09/2026
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
Anthony Tsang’s Strategic Control Could Be the Key to ATGL’s AI Transformation
icon
22/09/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.